Ifebemtinib plus garsorasib in previously treated metastatic colorectal cancer with KRASG12C mutation: a multicentre, randomised, phase 1b/2 trial
1. 系统已在2026-09-24 09:49:04对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s1470-2045(26)00175-0
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1470204526001750
其他信息:
出版社: Elsevier BV
作者: Zhengbo Song; Liming Zhu; Ying Liu; Rongbo Lin; Xingya Li; Yongzhong Luo; Yuan Yuan; Huaqiu Shi; Yiping Zhang; Baoyuan Zhang; Yinxin Zhu; Zaiqi Wang; Xiangdong Cheng

